NeuroKaire

Tel Aviv-yafo, Israel

NeuoKaire develops a personalized medical testing tool to better treat depression.

$10.0M raised

Dec 2024

Venture - Series Unknown

Top Investors

European Innovation CouncilMassChallengeMeron CapitalJumpspeed VenturesHoward Morgan

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NeuroKaire raised?

NeuroKaire has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2024.

Who are NeuroKaire's investors?

NeuroKaire's investors include European Innovation Council, MassChallenge, Meron Capital, Jumpspeed Ventures, Howard Morgan.

Where is NeuroKaire headquartered?

NeuroKaire is headquartered in Tel Aviv-yafo, Israel.

What does NeuroKaire do?

NeuoKaire develops a personalized medical testing tool to better treat depression.

What stage is NeuroKaire at?

NeuroKaire is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 17, 2024.

MLA

"NeuroKaire — Funding & Investors." VCBacked, December 17, 2024, https://www.vcbacked.co/company/neurokaire. Accessed June 4, 2026.

APA

VCBacked. (2024). NeuroKaire — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/neurokaire

Wikipedia (cite web)

{{cite web |title=NeuroKaire — Funding & Investors |url=https://www.vcbacked.co/company/neurokaire |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 17, 2024.